Press releases

For the first time in Europe, Tübingen physicians make use of an RNA therapy specifically tailored to one patient

Press release in German only

Press contact

Press contactProvisional Director of Communications

Silke DutzPhone 07071 29 88802silke.dutz@medizin.uni-tuebingen.deAddress

Hertie Institute for Clinical Brain Research
Director of Communications

Otfried-Müller-Str. 27
72076 Tübingen